MiRXES Co-Founder & CEO Lihan Zhou says the Chinese market is key, as it gives his company the scale to bring down cost. The Singapore-based biotechnology startup made its Hong Kong initial public offering debut. He speaks with Haslinda Amin on “Insight with Haslinda Amin.”
